Arzanian Mohammad Thaghi, Shamsian Bibi Shahin, Karimzadeh Parvaneh, Kajiyazdi Mohammad, Malek Fatima, Hammoud Mohammad
Pediatric Congenital Hematologic Disorders Research Center, Mofid Children Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Pediatric Neurologist, Mofid Children Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Iran J Child Neurol. 2014 Spring;8(2):1-10.
Posterior reversible encephalopathy syndrome (PRES) is a cliniconeuroradiological disease entity, which is represented by characteristic magnetic resonance imaging (MRI) findings of subcortical/cortical hyperintensity in T2-weighted sequences. It is more often seen in parietaloccipital lobes, and is accompanied by clinical neurological changes. PRES is a rare central nervous system (CNS) complication in patients with childhood hematologic-oncologic disese and shows very different neurological symptoms between patients, ranging from numbness of extremities to generalized seizure. In this article, we will review PRES presentation in hematologic-oncologic patients. Then, we will present our patient, a 7-year-old boy with Evans syndrome on treatment with cyclosporine, mycophenolate mofetil (MMF) and prednisone, with seizure episodes and MRI finding in favour of PRES.
后部可逆性脑病综合征(PRES)是一种临床神经放射学疾病实体,其特征为在T2加权序列上皮质下/皮质高信号的磁共振成像(MRI)表现。它更常见于顶枕叶,并伴有临床神经学改变。PRES是儿童血液肿瘤疾病患者中罕见的中枢神经系统(CNS)并发症,不同患者的神经症状差异很大,从肢体麻木到全身性癫痫发作不等。在本文中,我们将回顾血液肿瘤患者中PRES的表现。然后,我们将介绍我们的患者,一名7岁男孩,患有Evans综合征,正在接受环孢素、霉酚酸酯(MMF)和泼尼松治疗,出现癫痫发作,MRI检查结果支持PRES。